123 related articles for article (PubMed ID: 21485109)
1. [Perioperative management of neuroleptic malignant syndrome in a schizophrenic patient scheduled to undergo operation for bowel obstruction].
Kotera A; Kouzuma S; Miyazaki N; Hashimoto M; Taki K; Esaki K
Masui; 2011 Mar; 60(3):373-6. PubMed ID: 21485109
[TBL] [Abstract][Full Text] [Related]
2. [A study of neuroleptic malignant syndrome in the presenium and senium].
Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of neuroleptic malignant syndrome.
Guerrero RM; Shifrar KA
Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
[TBL] [Abstract][Full Text] [Related]
4. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report].
Mishima T; Tsuboi Y; Higuchi MA; Tsugawa J; Obata T; Yamada T
Brain Nerve; 2011 May; 63(5):503-7. PubMed ID: 21515931
[TBL] [Abstract][Full Text] [Related]
5. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
Aruna AS; Murungi JH
Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
[TBL] [Abstract][Full Text] [Related]
6. Detection and management of the neuroleptic malignant syndrome.
Bond WS
Clin Pharm; 1984; 3(3):302-7. PubMed ID: 6145537
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome: a review and report of six cases.
Kasantikul D; Kanchanatawan B
J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant syndrome occurring after an emergency operation for traumatic duodenal perforation: report of a case.
Honda M; Ueo H; Inoue H; Nanbara S; Arinaga S; Asoh T; Akiyoshi T
Surg Today; 1994; 24(3):276-9. PubMed ID: 7911692
[TBL] [Abstract][Full Text] [Related]
9. Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy.
Tsuchiya N; Morimura E; Hanafusa T; Shinomura T
Paediatr Anaesth; 2007 Mar; 17(3):281-4. PubMed ID: 17263746
[TBL] [Abstract][Full Text] [Related]
10. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
[TBL] [Abstract][Full Text] [Related]
11. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
Nisijima K; Ishiguro T
J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
[TBL] [Abstract][Full Text] [Related]
12. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Borovicka MC; Bond LC; Gaughan KM
Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
[TBL] [Abstract][Full Text] [Related]
13. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
Tsai JH; Yang P; Yen JY; Chen CC; Yang MJ
Pharmacotherapy; 2005 Aug; 25(8):1156-9. PubMed ID: 16207109
[TBL] [Abstract][Full Text] [Related]
14. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
[TBL] [Abstract][Full Text] [Related]
15. [Neuroleptic malignant syndrome: a rare long lasting case report].
Lemos J; Mós M; Monteiro A; Henriques P
Acta Med Port; 2010; 23(6):1155-9. PubMed ID: 21627894
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome secondary to quetiapine.
Gortney JS; Fagan A; Kissack JC
Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome among acute psychiatric admissions in Barbados.
Mansoor GA; Corbin DO; Edwards CN; Nicholson GD; Asokan G; Bannister P
West Indian Med J; 1992 Mar; 41(1):15-8. PubMed ID: 1566588
[TBL] [Abstract][Full Text] [Related]
18. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
[TBL] [Abstract][Full Text] [Related]
19. Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report.
Tsai MC; Huang TL
Chang Gung Med J; 2010; 33(5):576-80. PubMed ID: 20979709
[TBL] [Abstract][Full Text] [Related]
20. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
